The Ehlers-Danlos Syndrome (EDS) Gene Panel by NGS evaluates a wide range of genes associated with different subtypes of Ehlers-Danlos syndrome, a group of hereditary connective-tissue disorders. Using an EDTA blood sample, this test helps detect genetic variants linked to joint hypermobility, skin laxity, and tissue fragility. Metropolis Healthcare uses advanced next-generation sequencing to ensure precise mutation detection and high-quality reporting. The results support targeted diagnosis, clinical decision-making, and family counseling.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0192
Frequently Asked Questions (FAQ's):
What does the Ehlers-Danlos Syndrome Gene Panel include at Metropolis Healthcare?
It covers multiple genes associated with various EDS subtypes, analyzed using high-accuracy next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from EDTA blood and sequences the relevant genes through advanced NGS technology.
Who should consider taking this test at Metropolis Healthcare?
Individuals with joint hypermobility, frequent dislocations, stretchy skin, poor wound healing, or a family history of EDS may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is sufficient for reliable DNA extraction and sequencing.
How long does Metropolis Healthcare take to provide the results?
Turnaround time depends on sequencing and analysis procedures, with reports issued promptly after detailed evaluation.
Why choose Metropolis Healthcare for this genetic test?
Metropolis Healthcare ensures broad gene coverage, strict quality control, and clinically relevant interpretation.
Does Metropolis Healthcare offer post-test guidance?
Yes, results include expert genetic insights to help clinicians plan appropriate management and follow-up.
Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is appropriate for both children and adults when Ehlers-Danlos syndrome is suspected.